40. Amerikan Klinik Kanser Cemiyeti (ASCO) toplantisindan i̇zlenimler: Meme kanserinin adjuvan tedavisinde bisfosfonatlarin rolu

Kadri Altundaǧ; Banu Arun

40. Amerikan Klinik Kanser Cemiyeti (ASCO) toplantisindan i̇zlenimler: Meme kanserinin adjuvan tedavisinde bisfosfonatlarin rolu

Translated title of the contribution: Reports from Fourtieth American Society of Clinical Oncology (ASCO meeting): Bisphosphonate use in the adjuvant treatment of breast cancer

Kadri Altundaǧ, Banu Arun

Breast Medical Oncology

Research output: Contribution to journal › Article › peer-review

Abstract

Bisphosphonates have beneficial effects on bone metastases. The bisphosphonates are expected to reduce or prevent the incidence of bone metastases by inhibiting tumor-induced osteoclastic resorption of bone when they are used as an adjuvant treatment of breast cancer. We summarize four abstracts about the adjuvant use of bisphosphonates in breast cancer patients presented in fourtieth ASCO meeting 2004.

Translated title of the contribution	Reports from Fourtieth American Society of Clinical Oncology (ASCO meeting): Bisphosphonate use in the adjuvant treatment of breast cancer
Original language	Turkish
Pages (from-to)	179-181
Number of pages	3
Journal	THOD - Turk Hematoloji-Onkoloji Dergisi
Volume	14
Issue number	3
State	Published - 2004

ASJC Scopus subject areas

Hematology
Oncology

Cite this

@article{16c3288c551c434780cc8fd6ba1c000b,

title = "40. Amerikan Klinik Kanser Cemiyeti (ASCO) toplantisindan {\.i}zlenimler: Meme kanserinin adjuvan tedavisinde bisfosfonatlarin rolu",

abstract = "Bisphosphonates have beneficial effects on bone metastases. The bisphosphonates are expected to reduce or prevent the incidence of bone metastases by inhibiting tumor-induced osteoclastic resorption of bone when they are used as an adjuvant treatment of breast cancer. We summarize four abstracts about the adjuvant use of bisphosphonates in breast cancer patients presented in fourtieth ASCO meeting 2004.",

author = "Kadri Altundaǧ and Banu Arun",

year = "2004",

language = "Turkish",

volume = "14",

pages = "179--181",

journal = "THOD - Turk Hematoloji-Onkoloji Dergisi",

issn = "1301-8825",

publisher = "UHOD - Uluslararasi Hematoloji Onkoloji Dergisi",

number = "3",

}

TY - JOUR

T1 - 40. Amerikan Klinik Kanser Cemiyeti (ASCO) toplantisindan i̇zlenimler

T2 - Meme kanserinin adjuvan tedavisinde bisfosfonatlarin rolu

AU - Altundaǧ, Kadri

AU - Arun, Banu

PY - 2004

Y1 - 2004

N2 - Bisphosphonates have beneficial effects on bone metastases. The bisphosphonates are expected to reduce or prevent the incidence of bone metastases by inhibiting tumor-induced osteoclastic resorption of bone when they are used as an adjuvant treatment of breast cancer. We summarize four abstracts about the adjuvant use of bisphosphonates in breast cancer patients presented in fourtieth ASCO meeting 2004.

AB - Bisphosphonates have beneficial effects on bone metastases. The bisphosphonates are expected to reduce or prevent the incidence of bone metastases by inhibiting tumor-induced osteoclastic resorption of bone when they are used as an adjuvant treatment of breast cancer. We summarize four abstracts about the adjuvant use of bisphosphonates in breast cancer patients presented in fourtieth ASCO meeting 2004.

UR - http://www.scopus.com/inward/record.url?scp=4744345560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744345560&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:4744345560

SN - 1301-8825

VL - 14

SP - 179

EP - 181

JO - THOD - Turk Hematoloji-Onkoloji Dergisi

JF - THOD - Turk Hematoloji-Onkoloji Dergisi

IS - 3

ER -

40. Amerikan Klinik Kanser Cemiyeti (ASCO) toplantisindan i̇zlenimler: Meme kanserinin adjuvan tedavisinde bisfosfonatlarin rolu

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this